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Abstract 31 
Background 32 
Early repolarization (ER) has been linked to the risk of sudden cardiac death (SCD) in the general 33 
population, although controversy remains regarding risks across various subgroups. 34 
Objective 35 
We investigated whether age and sex influence the prognostic significance of ER. 36 
Methods 37 
We evaluated the 12-lead electrocardiograms of 6631 Finnish general population subjects aged ≥3038 
years (mean age 50.1 ± 13.9 years, 44.5% men) for the presence of ER (J-point elevation ≥0.1 mV 39 
in ≥2 inferior/lateral leads), following them for 24.4 ± 10.3 years. We analyzed the association 40 
between ER and the risk of SCD, cardiac death, and all-cause mortality in subgroups according to 41 
age (<50 or ≥50 years) and sex. 42 
Results 43 
ER was present in 367 of the 3305 subjects under 50 and in 426 of 3326 subjects aged ≥50 years. 44 
ER was not associated with any of the endpoints in he entire study population. After adjusting for 45 
clinical factors, ER was associated with SCD (hazard r tio [HR] 1.88; 95% confidence interval [CI] 46 
1.16–3.07) in subjects under 50, but not in older subjects (interaction between ER and age group, P 47 
= .048). Among the younger subgroup, women with ER had a high risk of SCD (HR 4.11; 95% CI 48 
1.41–12.03), whereas among men ER was not associated with SCD. Finally, ER was not associated 49 
with cardiac mortality or all-cause mortality in either age group. 50 
Conclusion 51 
ER associates with SCD in subjects younger than 50 years, particularly in women, but not in 52 
subjects 50 years and older. 53 
 54 
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Introduction 57 
An early repolarization (ER) pattern was previously considered a benign electrocardiogram (ECG) 58 
pattern, until it was shown to be associated with idiopathic ventricular fibrillation in three separate 59 
case-control studies in 2008.1–3 Subsequently, researchers found that ER was also associ ted with 60 
all-cause mortality, cardiac death, and sudden cardiac death (SCD) in the general population.4–8 61 
However, some studies found no link between ER and adverse events.7 Consequently, researchers 62 
attempted to distinguish benign ER patterns from patterns that associate with more unfavorable 63 
prognoses.5,9–12 Furthermore, other studies examined whether the prognosis associated with ER 64 
varies across different patient subgroups.6,9,11 In some studies ER was associated with cardiac 65 
mortality, particularly among younger middle-aged subjects, whereas in studies among older 66 
subjects ER was not associated with an excess risk.6,13 In young adult populations, however, ER is a 67 
prevalent finding and considered a benign phenomenon.14–16 Whether age affects the risk of SCD 68 
associated with ER in adult subjects remains unclear. 69 
 Here, we present our investigation of the associati n between ER and SCD, cardiac 70 
mortality, and all-cause mortality in a Finnish general population cohort and examine whether this 71 
association differs between subjects younger than 50 years old and those ≥50 years. Furthermore, 72 
we assess whether sex impacted the risk associated with ER in these age groups.  73 
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Methods 74 
Study population 75 
The study population consisted of participants of the Mini-Finland Health Survey, a representative 76 
sample of the Finnish population, conducted in 1978–19 0. The survey consisted of health 77 
interviews regarding the subjects’ health status, diseases, medications, symptoms, and lifestyle, 78 
together with health examinations that measured blood pressure, body mass index, and serum 79 
cholesterol, and included an electrocardiogram (ECG). In total, 8000 subjects aged ≥30 years were 80 
invited to take part, among whom 7217 participated in the health examination. The extensive survey 81 
methods are reported elsewhere.17 In total, 17 survey participants in this study also participated in a 82 
previous cohort study by Tikkanen et al.4 83 
 84 
Electrocardiographic measurement and analyses 85 
A standard 12-lead ECG was recorded with a paper speed of 50 mm/s for all study subjects during 86 
the health examinations conducted in 1978–1980, and subsequently stored for later assessment. The 87 
presence of an ER pattern was assessed manually from the original paper ECGs by three physicians 88 
in 2016–2018, with assistance from a cardiologist when needed.  89 
An ER pattern was defined and assessed based on a slightly modified version of the 90 
recommendations from a published consensus paper.18 Briefly, we defined an ER pattern as an end-91 
QRS notch or slur on the downward slope of the prominent R-wave at the J-point, with an 92 
amplitude of ≥0.1 mV measured with respect to the true baseline det rmined as the T–P segment. 93 
The presence of a pathological Q-wave in the lead with an end-QRS notch or slur was considered a 94 
possible peri-infarction block and not classified as an ER pattern.19 A subject’s ECG was 95 
considered positive for ER if an ER pattern was present in either ≥2 of the inferior (II, III, or aVF) 96 
or ≥2 of the lateral (I, aVL, V4, V5, or V6) leads. An ER amplitude was classified as ≥0.1 mV, but 97 
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<0.2 mV or ≥0.2 mV. Each ECG positive for ER was classified according to the configuration of 98 
the ER patterns as a slur, notch, or undetermined (o predominant form). The ST-segment was 99 
regarded horizontal or descending if the amplitude of the ST-segment 100 ms after the J-point was 100 
less than or equal to the amplitude at the J-point end, and ascending if the amplitude was greater 101 
than the amplitude at the J-point end.18 An ECG was classified as a low amplitude T-wave if any T-102 
wave in leads I, II, or V4–V6 was inverted, biphasic, or had an amplitude ≤0.1 mV and ≤10% of the 103 
R-wave amplitude in the same lead.12 104 
We excluded subjects (n = 248) with missing or unreadable ECGs and subjects (n = 105 
331) with II/III-degree atrioventricular block, ventricular pre-excitation, complete or incomplete 106 
bundle branch block, left anterior or posterior fascicular block, QRS duration >110 ms, a pacemaker 107 
rhythm, or rare ECG findings not representing the general population. We also excluded subjects (n 108 
= 7) with missing data. 109 
 110 
Follow-up 111 
Subjects were followed from the baseline examinatios in 1978–1980 until the end of 2011 using 112 
the Causes of Death Register maintained by Statistics Finland. SCDs likely caused by terminal 113 
arrhythmias were determined by two cardiologists. These cardiologists reviewed the data for all 114 
deaths from cardiovascular causes from death, hospital, and autopsy records using the SCD 115 
definitions based on the modified Cardiac Arrhythmia Suppression Trial (CAST) criteria.20 In cases 116 
of disagreement, a third cardiologist reviewed and classified the case. The primary endpoint was 117 
SCD, and the secondary endpoints were cardiac death and death from any cause. 118 
The Mini-Finland Health Survey preceded the current l gislation on ethics in medical 119 
research. All participants were fully informed about the survey and its implications, participated in 120 
the study voluntarily, and were advised that their information would be used for medical research. 121 
Agreeing to participate in the baseline health examin tion was taken to indicate their informed 122 
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consent. Record linkage with national health registrs o the survey data was approved by the 123 
register authorities.  124 
 125 
Statistical analysis 126 
Continuous data are presented as the mean ± standard deviation, while categorical data appear as 127 
the number of cases and prevalence in the study population in parentheses. We used the general 128 
linear model to compare the age- and sex-adjusted mean values for continuous variables, and the 129 
prevalence of categorical variables in cross-sectional baseline data. Hazard ratios (HRs), 95% 130 
confidence intervals (95% CIs), and P values were calculated using the Cox proportional hazards 131 
model. We tested the assumption for proportional hazards for each covariate in the final Cox 132 
regression model. Age, sex, systolic blood pressure, total serum cholesterol, smoking, diabetes, and 133 
coronary artery disease (CAD) were used as covariates n the multivariate models. The statistical 134 
significance of the effect modification by age group (subjects aged <50 years and ≥50 years, 135 
respectively) and sex were tested using the Wald test by entering an interaction term for ER and age 136 
group, and ER and sex, respectively. We considered P < .05 as statistically significant. All 137 
statistical analyses were performed using IBM SPSS Statistics (version 24) and R (version 3.6.1, 138 
https://www.r-project.org/).  139 
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Results 140 
Baseline characteristics of subjects 141 
Table 1 summarizes the baseline characteristics. ER was slightly more prevalent among subjects 142 
aged ≥50 years compared to subjects under 50 years (12.8% vs 11.1%; P = .033). Subjects with ER 143 
were more likely male than subjects without ER among subjects aged <50 (68.1% vs 45.7%; P <144 
.001). Yet, we found no significant sex difference in subjects ≥50 years. Subjects under 50 with ER 145 
had a lower systolic blood pressure, a lower heart rate, and a shorter QRS duration and QTc interval 146 
compared to subjects without ER after adjusting for age and sex. Subjects ≥50 years with ER had a 147 
lower heart rate and were less likely to have diabetes, but were more likely to take beta blocker 148 
medication compared to subjects without ER after adjusting for age and sex.  149 
 150 
Impact of age and sex on ER prognosis 151 
Among 3305 subjects under 50, 748 (22.6%) died during a mean follow-up of 30.2 ± 6.4 years, 152 
among whom 237 died from cardiac causes (31.7% of all de ths), and 95 from SCD (12.7% of all 153 
deaths). Among those ≥50 years old, 2819 of 3326 subjects (84.8%) died during a mean follow-up 154 
of 18.7 ± 10.2 years. Among those who died, 1283 deaths resulted from cardiac causes (45.5% of 155 
all deaths) and 251 from SCD (8.9% of all deaths).  156 
Across the entire study population, ER was not associated with any of the endpoints 157 
(see Supplemental Material). Furthermore, from the diff rent ER patterns, only ER with a low 158 
amplitude T-wave (n=158 [19.9% of ER subjects], multivariate-adjusted HR 1.75; 95% CI 1.06–159 
2.87; P = .027) was associated with SCD in the entire study population when compared to subjects 160 
without ER (see Supplemental Material). Table 2 shows the risk for SCD and the secondary 161 
endpoints associated with ER in the age subgroups, and the interaction between ER and age group. 162 
ER was not associated with cardiac death or all-cause mortality in either age group. During the 163 
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follow-up period, 5.7% of subjects with ER and 2.5% of subjects without ER under 50 suffered an 164 
SCD, compared to 7.7% with and 7.5% without ER, respectively, ≥50 years old. We detected a 165 
significant interaction between ER and the age group in SCD (multivariate-adjusted P = .048). In 166 
addition, ER was associated with an increased risk of SCD in subjects under 50 in the multivariate 167 
analysis (HR 1.88; 95% CI 1.16–3.07; P = .011), whereas among subjects ≥50 years ER was not 168 
associated with an increased SCD risk. Figure 1 provides the survival plots according to age group 169 
for SCD adjusted for confounders. 170 
Among subjects under 50, we detected a significant interaction between ER and sex in 171 
SCD after adjusting for age (P = .024), which did not remain significant in the multivariate analysis 172 
(P = .092). When women under 50 were analyzed separately, ER was associated with a high risk of 173 
SCD in both the age-adjusted (HR 5.34; 95% CI 1.88–15.19; P = .002) and multivariate-adjusted 174 
(HR 4.11; 95% CI 1.41–12.03; P = .010) analyses when compared to subjects without ER. Figure 2 175 
provides an example ER pattern from a woman under 50 years old. In comparison, ER was not 176 
associated with SCD among men under 50. Neither men nor women under 50 with ER exhibited an 177 
increased risk for cardiac death or all-cause mortality.  178 
 179 
Risk of SCD based on the ER pattern in subjects under 50 180 
Table 3 summarizes the risks of SCD based on the ER pattern among subjects under 50 in the 181 
multivariate analyses. When assessed by ER localization, both inferior (HR 1.92; 95% CI 1.04–182 
3.56; P = .038) and lateral (HR 2.08; 95% CI 1.10–3.95; P = .024) ER localizations were associated 183 
with SCD risk among subjects under 50. Furthermore, a slurred ER (HR 2.09; 95% CI 1.19–3.67; P 184 
= .010), ER with a horizontal or descending ST-segmnt (HR 3.12; 95% CI 1.56–6.26; P = .001), 185 
and ER with a low amplitude T-wave (HR 4.47; 95% CI 1.75–11.42; P = .002) were associated 186 
with SCD risk among subjects under 50 years old.   187 
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Discussion 188 
We evaluated the prognosis associated with ER based on sex and age groups in a large 189 
representative population cohort with a long follow-up period. We found that ER was associated 190 
with an increased risk of SCD among adults aged 30–50 years, whereas no increased SCD risk was 191 
observed among subjects with ER aged ≥50 years. Furthermore, among subjects under 50, women 192 
with ER exhibited a high SCD risk, whereas ER was not associated with SCD among men.   193 
In this study, ER prevalence reached 12.0% in the entire study population. In previous 194 
studies, the prevalence of ER ranged from 0.9% to 23.9%.7,8,21 We defined ER following minor 195 
adjustments as recommended in a recent consensus paper. We measured the ER amplitude with 196 
respect to the true baseline determined as the T–P segment, compared to with respect to the QRS 197 
onset suggested by the consensus paper. This differenc  could have had an effect on the ER 198 
amplitude measurements, especially on tachycardic subjects. The ER definition used in the present 199 
study is similar albeit somewhat modified to that used in a previous Finnish middle-aged general 200 
population cohort study in which ER prevalence was 5.8%.4,10,18 A possible explanation for the 201 
difference in the ER prevalence between these studies may lie in the improved ECG quality in the 202 
present study given the more modern recording device, as borderline cases would be determined ER 203 
positive in the present study and negative in the previous study. Concordant with previous studies, 204 
ER was more prevalent among men younger than 50, whereas no sex difference was identified 205 
among older subjects.16 One possible explanation for this may lie in the association between ER and 206 
testosterone levels in men, which begin declining before the age of 50.22 207 
Previously, few studies examined ER prognosis in different age groups. In a German 208 
cohort study, ER was associated with all-cause and c r iac mortality among subjects aged 35–54, 209 
while ER was not associated with an adverse prognosis in older age groups.6 Similarly, in a 210 
Japanese cohort study, subjects aged <60 years with ER exhibited an increased risk for cardiac 211 
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death, while subjects with ER ≥60 years carried no such increased risk.13 However, in young adults 212 
aged 18–30 in the United States, ER with an ascending ST-segment was not associated with adverse 213 
outcomes, and the prevalence of ER markedly decreased during the follow-up period.14 214 
Interestingly, the prevalence of ER with an ascending ST-segment appears to change in male and 215 
female subjects throughout puberty, while the prevalence of ER with a horizontal or descending ST-216 
segment remains fairly constant among children, adolescents, and middle-aged subjects.10,15,23  217 
To our knowledge, no previous studies examined the impact of age on SCD risk related 218 
to ER. In our study, subjects aged 30–50 years exhibited an increased risk of SCD, while ≥50-year-219 
old subjects with ER showed no increase in SCD risk. Previous studies demonstrated that ER may 220 
predispose an individual to a fatal arrhythmia during ischemic or nonischemic events.11,24 This 221 
vulnerability could manifest after a longer time period, perhaps explaining why ER was associated 222 
with SCD only among the younger subjects in our study. Furthermore, older subjects may have died 223 
due to other comorbidities before a critical event occurred. A plausible explanation could then be 224 
that ER in young adults, particularly with an ascending ST-segment, represents a benign ECG 225 
finding that normally disappears before middle age. This stands in contrast to a more constant and 226 
unchanging ER with a descending or horizontal ST-segment, which associates with a long-term 227 
vulnerability to more nefarious arrhythmias.14–16 It may also be that the most malign ER phenotypes 228 
manifest at a younger age and, thus, the more benign ER phenotypes may be overrepresented 229 
among the very old. Moreover, as the risk of SCD increases with age, other factors may associate 230 
with SCD risk more strongly than ER in older indiviuals.  231 
Previous studies have provided contradictory results on the impact of sex on ER 232 
prognosis. For example, a German study found that ER was associated with cardiac mortality in a 233 
subgroup of men, but not among women.6 I  contrast, a cohort study from the United States 234 
demonstrated an association between ER and SCD only among women.9 However, in the same 235 
study population, automatically detected ER was associated with cardiovascular mortality only 236 
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among men.25 We, however, observed an association between ER and the risk of SCD in women 237 
under 50, but not among men. 238 
Various studies provide a large degree of heterogeneous results in their examinations 239 
of the risk associated with ER among general populations, with several studies finding no link 240 
between ER and an increased risk of adverse outcomes.7,9,21 In the present study, we found that ER 241 
was not associated with SCD, cardiac mortality, or all-cause mortality across the entire study 242 
population. Possible explanations for these contradicting results across studies include the different 243 
study population characteristics, follow-up periods, and ER definitions applied. In addition, only a 244 
small minority of subjects with ER will eventually experience SCD, while the majority will enjoy 245 
benign prognoses. Therefore, future research should c ntinue to refine or better define the specific 246 
patient characteristics and ER pattern features to more accurately identify that minority of 247 
individuals who will suffer an SCD. Better identifying such individuals will ultimately serve to 248 
improve their prognosis. 249 
 250 
Limitations 251 
Although the subjects underwent extensive health interviews and examinations at the beginning of 252 
the survey, the subjects’ health status or the presence of ER in ECG were not reassessed during the 253 
follow-up period. Therefore, we had no information on whether participants’ health status, 254 
comorbidities, or ER status changed during the follow-up period. Yet, ER has been shown to be 255 
relatively stable ECG finding among middle-aged subjects.4 A further limitation to this study lies in 256 
the study population, which consisted of only Caucasian subjects. Thus, these results are not 257 
directly generalizable to other ethnicities. 258 
 259 
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Conclusions 260 
In conclusion, among adults aged 30–50 years, ER associates with SCD. In particular, women under 261 
50 years old with ER exhibited a higher risk of SCD, while ER was not associated with SCD among 262 
men <50 years old. In addition, we found that among subjects ≥50 years old, ER was not associated 263 
with an adverse prognosis at all. Future research should focus on identifying factors that account for 264 
the differences between age groups, and improving the risk stratification in younger patient 265 
populations with ER. 266 
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Tables 342 
Table 1 343 
Baseline characteristics 344 
  
All 
n = 6631  
Age <50 years 
n = 3305   
Age ≥50 years 
n = 3326 
  
No ER 
n = 5838 
(88.0%) 
ER 
n = 793 
(12.0%) P  
No ER 
n = 2938 
(88.9%) 
ER 
n = 367 
(11.1%) P  
No ER 
n = 2900 
(87.2%) 
ER 
n = 426 
(12.8%) P 
Male (%)† 
2522 
(43.2%) 
432 
(54.5%) 
< .001  
1342 
(45.7%) 
250 
(68.1%) 
< .001 
 
1180 
(40.7%) 
182 
(42.7%) 
.405 
Age (years)‡ 
51.0 
±13.9 
52.1 
±13.8 
.006  
39.3 
±5.8 
39.6 
±5.9 
.434  
62.7 
±8.8 
62.9 
±8.6 
.680 
Systolic blood  
pressure (mmHg)§ 
143.2 
±23.2 
143.0 
±22.3 
.074  
132.3 
±16.6 
131.9 
±15.2 
.033  
154.3 
±23.7 
152.5 
±23.0 
.114 
Diastolic blood  
pressure (mmHg)§ 
86.8 
±11.5 
87.2 
±11.5 
.633  
84.9 
±11.2 
85.6 
±10.9 
.397  
88.8 
±11.5 
88.6 
±11.9 
.661 
Body mass index 
(kg/m2)§ 
25.9 
±4.1 
26.2 
±4.1 
.082  
25.0 
±3.8 
25.3 
±3.6 
.583  
26.8 
±4.2 
26.9 
±4.4 
.425 
Cholesterol (mmol/l, 
mg/dl)§ 
6.9  
±1.4 
268 
±53 
7.1  
±1.5 
274 
±57 
.008  
6.6  
±1.3 
254 
±48 
6.7  
±1.3 
260 
±49 
.293  
7.3  
±1.4 
283 
±53 
7.4  
±1.6 
286 
±61 
.164 
Heart rate (bpm)§ 
69  
±14 
65  
±12 
< .001  
67  
±12 
63  
±11 
< .001  
71  
±15 
66  
±14 
< .001 
QRS duration (ms)§ 85  85  .079  86  86  .001  85  85  .793 
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±9 ±8 ±9 ±8 ±9 ±8  
QTc interval (ms)§ 
404 
±24 
400 
±25 
.004  
400 
±23 
393 
±25 
.009  
407 
±24 
405 
±24 
.254 
Smoking (%)§ 
1266 
(21.7%) 
199 
(25.1%) 
.291  
779 
(26.5%) 
118 
(32.2%) 
.544  
487 
(16.8%) 
81 
(19.1%) 
.301 
Diabetes (%)§ 
320 
(5.5%) 
27 
(3.4%) 
.002  
34 
(1.2%) 
4 
(1.1%) 
.662  
286 
(9.9%) 
23 
(5.4%) 
.002 
Coronary artery 
disease (%)§ 
603 
(10.3%) 
76 
(9.6%) 
.067  
55 
(1.9%) 
8 
(2.2%) 
.987  
548 
(18.9%) 
68 
(16.0%) 
.107 
Beta blocker 
medication (%)§ 
370 
(6.3%) 
73 
(9.2%) 
.007  
88 
(3.0%) 
17 
(4.6%) 
.136  
282 
(9.7%) 
56 
(13.1%) 
.029 
 345 
ER = early repolarization; QTc = QT corrected for heart rate using Bazett’s formula. Continuous 346 
data are presented as means ± standard deviation, while categorical data are presented as the 347 
number of cases (% of study population). Statistical est for the difference between subjects with 348 
and without ER in all subjects, subjects aged <50 years, and subjects aged ≥50 years.  349 
†Adjusted for age.  350 
‡Adjusted for sex.  351 
§Adjusted for age and sex.  352 
  353 
 
 
 18
Table 2 354 
Risk of sudden cardiac death, cardiac death, and death from any cause associated with ER in 355 
subjects aged <50 years and subjects aged ≥50 years 356 
 357 
    
Age <50 years 
n = 3305   
Age ≥50 years 
n = 3326   
ER*age group 
interaction 
    
No ER 
n = 2938 
ER 
n = 367   
No ER 
n = 2900 
ER 
n = 426   P 
SCD               
  
# of SCDs 
(# of SCDs in men) 
74 
(62) 
21 
(16) 
  
218 
(123) 
33 
(19) 
    
  
Age- and sex-adjusted  
HR (95% CI) 
1 
1.72 
(1.05–2.80) 
  1 
1.01 
(0.70–1.46) 
  .045 
  
Multivariate-adjusted  
HR (95% CI) 
1 
1.88 
(1.16–3.07) 
  1 
1.01 
(0.70–1.46) 
  .048 
Cardiac death               
  
# of cardiac deaths 
(# of cardiac deaths in men) 
199 
(150) 
38 
(31) 
  
1112 
(507) 
171 
(82) 
    
  
Age- and sex-adjusted  
HR (95% CI) 
1 
1.20 
(0.85–1.70) 
  1 
1.03 
(0.88–1.21) 
  .170 
  
Multivariate-adjusted  
HR (95% CI) 
1 
1.13 
(0.79–1.60) 
  1 
1.08 
(0.92–1.27) 
  .175 
Death               
  
# of deaths 
(# of deaths in men) 
649 
(404) 
99 
(75) 
  
2442 
(1052) 
377 
(166) 
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Age- and sex-adjusted  
HR (95% CI) 
1 
1.05 
(0.85–1.30) 
  1 
1.04 
(0.93–1.16) 
  .585 
  
Multivariate-adjusted  
HR (95% CI) 
1 
1.03 
(0.83–1.28) 
  1 
1.07 
(0.96–1.19) 
  .620 
 358 
ER = early repolarization; SCD = sudden cardiac death. The hazard ratios (HRs) and 95% 359 
confidence intervals (CIs) were calculated using the Cox proportional hazards model. Variables 360 
included in the multivariate analyses were age as a continuous variable, sex, systolic blood pressure, 361 
total serum cholesterol, coronary artery, diabetes, smoking, and ER. The effect modification was 362 
tested by entering an interaction term for ER and the age group in the multivariate analysis. 363 
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Table 3 364 
Risk of sudden cardiac death according to the ER pattern in subjects aged <50 years 365 
  
Age <50 years 
n = 3305 
  
# of 
subjects 
# of 
SCDs 
Age- and sex-adjusted 
HR (95% CI) 
Multivariate-adjusted 
HR (95% CI) 
No ER 2938 74 1 1 
Inferior/lateral ER 367 21 1.72 (1.05–2.80) 1.88 (1.16–3.07) 
Inferior ER 213 12 1.72 (0.93–3.19) 1.92 (1.04–3.56) 
Lateral ER 174 11 1.80 (0.95–3.39) 2.08 (1.10–3.95) 
Slurred inferior/lateral ER 251 15 1.82 (1.04–3.18) 2.09 (1.19–3.67) 
Notched inferior/lateral ER 74 4 1.59 (0.58–4.37) 2.28 (0.82–6.31) 
Inferior/lateral ER, ascending ST-segment 253 12 1.34 (0.72–2.47) 1.45 (0.78–2.67) 
Inferior/lateral ER, horizontal or descending 
ST-segment 
114 9 2.74 (1.37–5.47) 3.12 (1.56–6.26) 
Inferior/lateral ER ≥0.1 mV but <0.2 mV 300 21 2.00 (1.23–3.25) 2.16 (1.33–3.52) 
Inferior/lateral ER ≥0.2 mV 46 0 — — 
Low amplitude T-wave 29 5 6.79 (2.73–16.89) 4.47 (1.75–11.42) 
 366 
The hazard ratios (HRs) and 95% confidence intervals (CIs) for sudden cardiac death were 367 
calculated using the Cox proportional hazards model. Variables included in the multivariate 368 
analyses were age, sex, systolic blood pressure, total serum cholesterol, diabetes, smoking, coronary 369 
artery disease, and the ER pattern. 370 
  371 
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Figures 372 
Figure 1 373 
 374 
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Figure 1 legend 375 
Survival plots of A) subjects aged <50 years and B) subjects aged ≥50 years with and without ER 376 
for sudden cardiac death (SCD), adjusted for age, sex, systolic blood pressure, total serum 377 
cholesterol, smoking, diabetes, and coronary artery disease.  378 
  379 
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Figure 2 380 
 381 
Figure 2 legend 382 
Forty-five-year-old woman with typical inferior ER pattern with horizontal ST-segments. She died 383 
of sudden cardiac death during the follow-up period. Paper speed is 50 mm/s. Arrows indicate the 384 
ER patterns. 385 
Table 1
Baseline characteristics
No ER
n = 5838
(88.0%)
ER
n = 793 
(12.0%) P
No ER
n = 2938
(88.9%)
ER
n = 367
(11.1%) P
No ER
n = 2900
(87.2%)
ER
n = 426
(12.8%) P
Male (%)† 2522 (43.2%) 432 (54.5%) < .001 1342 (45.7%) 250 (68.1%) < .001 1180 (40.7%) 182 (42.7%) .405
Age (years)‡
51.0 
±13.9
52.1 
±13.8
.006
39.3 
±5.8
39.6 
±5.9
.434
62.7 
±8.8
62.9 
±8.6
.68
Systolic blood 
pressure (mmHg)§
143.2 
±23.2
143.0 
±22.3
.074
132.3 
±16.6
131.9 
±15.2
.33
154.3 
±23.7
152.5 
±23.0
.114
Diastolic blood 
pressure (mmHg)§
86.8 
±11.5
87.2 
±11.5
.633
84.9 
±11.2
85.6 
±10.9
.397
88.8 
±11.5
88.6 
±11.9
.661
Body mass index 
(kg/m2)§
25.9 
±4.1
26.2 
±4.1
.082
25.0 
±3.8
25.3 
±3.6
.583
26.8 
±4.2
26.9 
±4.4
.425
Cholesterol 
(mmol/l, mg/dl)§
6.9  
±1.4,
265 
±53
7.1 
±1.5,
274 
±57
.008
6.6 
±1.3,
254 
±48
6.7 
±1.3,
260 
±49
.293
7.3 
±1.4,
283 
±53
7.4 
±1.6,
286 
±61
.164
Heart rate (bpm)§
69 
±14
65 
±12
< .001
67 
±12
63 
±11
< .001
71 
±15
66 
±14
< .001
QRS duration (ms)§
85 
±9
85 
±8
.079
86 
±9
86 
±8
.001
85 
±9
85 
±8
.793
QTc interval (ms)§
404 
±24
400 
±25
.004
400 
±23
393 
±25
.009
407 
±24
405 
±24
.254
Smoking (%)§ 1266 (21.7%) 199 (25.1%) .291 779 (26.5%) 118 (32.2%) .544 487 (16.8%) 81 (19.1%) .301
Diabetes (%)§ 320 (5.5%) 27 (3.4%) .002 34 (1.2%) 4 (1.1%) .662 286 (9.9%) 23 (5.4%) .002
Coronary artery disease 
(%)§
603 (10.3%) 76 (9.6%) .067 55 (1.9%) 8 (2.2%) .987 548 (18.9%) 68 (16.0%) .107
All
n = 6631
Age <50 years
n = 3305
Age ≥50 years
n = 3326
Beta blocker 
medication (%)§
370 (6.3%) 73 (9.2%) .007 88 (3.0%) 17 (4.6%) .136 282 (9.7%) 56 (13.1%) .004
ER = early repolarization; QTc = QT corrected for heart rate using Bazett’s formula. 
† Adjusted for age.
Continuous data are presented as means ± standard deviation, while categorical 
data are presented as the number of cases (% of study population). Statistical 
test for the difference between subjects with and without ER in all subjects, 
subjects aged <50 years, and subjects aged ≥50 years. 
Table 2
Risk of sudden cardiac death, cardiac death, and death from any cause associated with ER in subjects aged <50 years and subjects aged ≥50 years
ER*age group
interaction
No ER
n = 2938
ER
n = 367
No ER
n = 2900
ER
n = 426 P
# of SCDs
(# of SCDs in men)
74
(62)
21
(16)
218
(123)
33
(19)
Age- and sex-adjusted 
HR (95% CI)
1 1.72 (1.05–2.80) 1 1.01 (0.70–1.46) 0.045
Multivariate-adjusted 
HR (95% CI)
1 1.88 (1.16–3.07) 1 1.01 (0.70–1.46) 0.048
# of cardiac deaths
(# of cardiac deaths in men)
199
(150)
38
(31)
1112
(507)
171
(82)
Age- and sex-adjusted  
HR (95% CI)
1 1.20 (0.85–1.70) 1 1.03 (0.88–1.21) 0.170
Multivariate-adjusted 
HR (95% CI)
1 1.13 (0.79–1.60) 1 1.08 (0.92–1.27) 0.175
# of deaths
(# of deaths in men)
649
(404)
99
(75)
2442
(1052)
377
(166)
Age- and sex-adjusted 
HR (95% CI)
1 1.05 (0.85–1.30) 1 1.04 (0.93–1.16) 0.585
Multivariate-adjusted 
HR (95% CI)
1 1.03 (0.83–1.28) 1 1.07 (0.96–1.19) 0.620
Age <50 years
n = 3305
Age ≥50 years
n = 3326
SCD
Cardiac death
Death
ER = early repolarization; SCD = sudden cardiac death. The hazard ratios (HRs) and 95% confidence 
intervals (CIs) were calculated using the Cox propotional hazards model. Variables included in the 
multivariate analyses were age as a continuous variable, sex, systolic blood pressure, total serum cholesterol, 
coronary artery, diabetes, smoking, and ER. The effect modification was tested by entering an interaction 
term for ER and the age group in the multivariate analysis.
Table 3
Risk of sudden cardiac death according to the ER pattern in subjects aged <50 years
# of 
subjects
# of SCDs
Age- and sex-adjusted
HR (95% CI)
Multivariate adjusted
HR (95% CI)
No ER 2938 74 1 1
Inferior/lateral ER 367 21 1.72 (1.05–2.80) 1.88 (1.16–3.07)
Inferior ER 213 12 1.72 (0.93–3.19) 1.92 (1.04–3.56)
Lateral ER 174 11 1.80 (0.95–3.39) 2.08 (1.10–3.95)
Slurred inferior/lateral ER 251 15 1.82 (1.04–3.18) 2.09 (1.19–3.67)
Notched inferior/lateral ER 74 4 1.59 (0.58–4.37) 2.28 (0.82–6.31)
Inferior/lateral ER, ascending ST segment 253 12 1.34 (0.72–2.47) 1.45 (0.78–2.67)
Inferior/lateral ER, horizontal or descending ST segm nt 114 9 2.74 (1.37–5.47) 3.12 (1.56–6.26)
Inferior/lateral ER ≥0.1 mV but <0.2 mV 300 21 2.00 (1.23–3.25) 2.16 (1.33–3.52)
Inferior/lateral ER ≥0.2 mV 46 0 - -
Low amplitude T-wave 29 5 6.79 (2.73–16.89) 4.47 (1.75–11.42)
The hazard ratios (HRs) and 95% confidence intervals (CIs) 
for sudden cardiac death were calculated using the Cox 
proportional hazards model. Variables included in the 
multivariate analyses were age, sex, systolic blood pressure, 
total serum cholesterol, diabetes, smoking, coronary artery 
disease, and the ER pattern.
Age <50 years
n = 3305
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Supplemental Table 1 2 
Risk of sudden cardiac death, cardiac death, and death from any cause associated with ER in the 3 
entire study population 4 
    
All 
n = 6631 
    
No ER 
n = 5838 
ER 
n = 793 
SCD     
  # of SCDs 292 54 
  Age- and sex-adjusted HR (95% CI) 1 1.22 (0.91-1.63) 
  Multivariate-adjusted HR (95% CI) 1 1.23 (0.92-1.64) 
Cardiac death     
  # of cardiac deaths 1311 209 
  Age- and sex-adjusted HR (95% CI) 1 1.07 (0.93-1.24) 
  Multivariate-adjusted HR (95% CI) 1 1.12 (0.96-1.29) 
Death     
  # of deaths 3091 476 
  Age- and sex-adjusted HR (95% CI) 1 1.05 (0.95-1.15) 
  Multivariate-adjusted HR (95% CI) 1 1.07 (0.97-1.18) 
 5 
ER = early repolarization; SCD = sudden cardiac death.  6 
The hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using the Cox 7 
proportional hazards model. Variables included in the multivariate analyses were age as a 8 
continuous variable, sex, systolic blood pressure, total serum cholesterol, coronary artery, diabetes, 9 
smoking, and ER.   10 
 
 
 3
Supplemental Table 2 11 
Risk of sudden cardiac death according to the ER pattern in the entire study population  12 
  
All  
n = 6631 
  
# of 
subjects 
# of 
SCDs 
Age- and sex-
adjusted 
HR (95% CI) 
Multivariate-adjusted 
HR (95% CI) 
No ER 5838 292 1 1 
Inferior/lateral ER 793 54 1.22 (0.91–1.63) 1.23 (0.92–1.64) 
Inferior ER 392 27 1.29 (0.87–1.92) 1.26 (0.85–1.88) 
Lateral ER 429 30 1.20 (0.82–1.75) 1.25 (0.86–1.82) 
Slurred inferior/lateral ER 555 38 1.25 (0.89–1.75) 1.26 (0.90–1.76) 
Notched inferior/lateral ER 138 10 1.26 (0.67–2.37) 1.29 (0.68–2.43) 
Inferior/lateral ER, ascending ST segment 470 28 1.04 (0.71–1.54) 1.10 (0.75–1.63) 
Inferior/lateral ER, horizontal or descending 
ST segment 
323 26 1.49 (1.00–2.23) 1.39 (0.93–2.09) 
Inferior/lateral ER ≥0.1 mV but <0.2 mV 680 47 1.27 (0.93–1.73) 1.27 (0.93–1.73) 
Inferior/lateral ER ≥0.2 mV 113 7 0.98 (0.46–2.07) 1.00 (0.47–2.12) 
Low amplitude T-wave 158 17 1.85 (1.13–3.03) 1.75 (1.06–2.87) 
 13 
The hazard ratios (HRs) and 95% confidence intervals (CIs) for sudden cardiac death (SCD) were 14 
calculated using the Cox proportional hazards model. Variables included in the multivariate 15 
analyses were age, sex, systolic blood pressure, total serum cholesterol, diabetes, smoking, coronary 16 
artery disease and the ER pattern. 17 
 18 
